BioXcel Therapeutics, Inc. Interest Payable, Current
BioXcel Therapeutics, Inc. (BTAI) had Interest Payable, Current of $79.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2025-03-28
- 2024-06-30: Interest Payable, Current $79.00K.
- 2024-03-31: Interest Payable, Current $117.00K.
- 2023-12-31: Interest Payable, Current $736.00K.
- 2023-09-30: Interest Payable, Current $567.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2024-06-30 | $79.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $117.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $736.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $567.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $3.11M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.09M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.17M 10-K · filed 2024-03-22 |
| 2022-09-30 | $2.90M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |